3rd Quarter - Report

THE LENKER GROUP LLC for SHIRE PLC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

User fees, drug shortages, DEA quotas, enantiomers, exclusivity periods, orphan drugs, health care reform implementation, drug innovation and patient access, approval pathways, priority vouchers; ESRD PPS, pharmaceutical and biotech related legislation; issues surrounding ADHD, tax reform, drug importation

Foreign entity interest: Shire has its headquarters in Wayne, PA. Its ultimate parent is parent is incorporated in Jersey.

LobbyistCovered position, as disclosed
MARK LENKER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.